Cardiovascular Diseases & Diagnosis

Finet GM

Publications

• Research Article
  Clinical Impact and Prognosis of Pulmonary Hypertension after Transcatheter Aortic Valve Implantation
  Author(s): Green Lisa, Rioufol G, Vergnat M, Obadia JF, Saroul C, Gevigney GDD, Cudraz EB, Croisille P and Finet GMGreen Lisa, Rioufol G, Vergnat M, Obadia JF, Saroul C, Gevigney GDD, Cudraz EB, Croisille P and Finet GM
  
  Background: Transcatheter Aortic Valve Implantation (TAVI) is a therapeutic option for patients presenting with severe aortic stenosis and in whom surgery is contraindicated. Pre-procedural Pulmonary Hypertension (PH) has been shown to be a factor of poor prognosis in surgical and TAVI studies. Aims: We sought to evaluate the clinical impact and prognostic implications of the presence of post-TAVI PH. Methods: The outcome of post-TAVI Pulmonary Artery Systolic Pressure (PASP) was studied in 58 high-risk patients with severe symptomatic aortic stenosis, by assessing clinical presentation and prognosis and determining predictive factors. Results: Post-TAVI PH (PASP>40 mmHg) affected 43% of patients at 6 months. Despite excellent aortic results in both groups, patients with post-TAVI PH w.. Read More»
  DOI: 10.4172/2329-9517.1000143

  Abstract PDF